CVR: 46294238
Not available
TLA-HOLDING 2010 ApS, Bastholm-Hansen Holding ApS
4 more
CVR · view ownership and management
Name registered: Hazel Therapeutics ApS
CVR · 19/02/2026
View the full event history
Hazel Therapeutics ApS is a Danish company of the type Anpartsselskab based in København SV, founded in 2026. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Ditte Elisabeth Jæhger. The company's owners include TLA-HOLDING 2010 ApS, Bastholm-Hansen Holding ApS and JHSCI Holding ApS.
Virksomhedens formål er at drive forskning, udvikling og kommercialisering af farmaceutiske produkter samt dermed beslægtet virksomhed
No annual financial figures are available for this company.
Screen owners and management against the Danish FSA's official PEP lists
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationHazel Therapeutics ApS was founded on 19 February 2026.
Hazel Therapeutics ApS is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (industry code 721000).
The owners of Hazel Therapeutics ApS include TLA-HOLDING 2010 ApS, Bastholm-Hansen Holding ApS and JHSCI Holding ApS.
hazel-tx.com belongs to Hazel Therapeutics ApS, CVR number 46294238.
The management of Hazel Therapeutics ApS consists of Ditte Elisabeth Jæhger.
Hazel Therapeutics ApS is located at c/o Ditte Elisabeth Jæhger, Martin Luther Kings Vej 23 st. tv, 2450 København SV.
Claim this page to add your logo and social links. Free to get started.
Contact info changed: new email: [email protected], new website: www.hazel-tx.com (May 13, 2026).
As of February 19, 2026, Lorentzen & Partners, Statsautoriserede Revisorer ApS has been appointed auditor of Hazel Therapeutics ApS.
As of February 19, 2026, Ditte Elisabeth Jæhger is registered as adm. dir. of Hazel Therapeutics ApS.
As of February 19, 2026, TLA-HOLDING 2010 ApS is registered as an owner of Hazel Therapeutics ApS with an ownership share of 15%.
As of February 19, 2026, Bastholm-Hansen Holding ApS is registered as an owner of Hazel Therapeutics ApS with an ownership share of 10%.
As of February 19, 2026, JHSCI Holding ApS is registered as an owner of Hazel Therapeutics ApS with an ownership share of 10%.
As of February 19, 2026, Verdande Holding ApS is registered as an owner of Hazel Therapeutics ApS with an ownership share of 33%.
As of February 19, 2026, Mitalone Holding ApS is registered as an owner of Hazel Therapeutics ApS with an ownership share of 10%.
As of February 19, 2026, is registered as an owner of Hazel Therapeutics ApS with an ownership share of 5%.
Hazel Therapeutics ApS was founded on February 19, 2026.
Companies in the same industry and area
CVR 45950263
CVR 40633979
CVR 31888263
CVR 35249389
CVR 37663808
